SUMO1P4

Across TCGA pan-cancer cohorts, SUMO1P4 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of SUMO1P4’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where SUMO1P4 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types SUMO1P4 is over-expressed in tumor, although a few such as KICH show the opposite, repressed pattern.

KIRC, KICH, and LUSC are the cancer types where SUMO1P4 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SUMO1P4 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Female	IV	+0.281	.006	4	view →
KICH	All	All	−0.227	.001	3	view →
LUSC	All	All	+0.167	.002	3	view →
UCEC	All	IV	+0.585	.012	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

SUMO1P4–KIRC

Open the KIRC breakdown →